Approximately, 75% of sporadic GIST are associated with KIT oncogenic mutations, which constitutively activate the receptor tyrosine kinase and KIT-dependent signaling pathways that end up in increasing the cell proliferation and apoptosis [18]. The gene discussed is NTRK1; the disease is gastrointestinal stromal tumor.